Fig. 5

Neuroprotective effect of ASF extracts on oxidative stress and apoptosis in scopolamine-treated mice. The activities of SOD (A), the level of MDA (B) and the activities of GSH-Px (C) were determined by commercial assay kits; Representative western blotting images (D) and fold changes in relative densitometric values (E, F, G) of Nrf2, Bax, Bcl-2 were determined by western blotting assays. (n = 3). Data were analysed as mean ± SE (n = 3). ^#p < 0.05, ^##p < 0.01 and ^###p < 0.001 compared to the control group; *p < 0.05, **p < 0.01 and ***p < 0.001 compared to the scopolamine-treated group